Narrow Results Clear All
Search results for "Pharmacy"
Journal Article > Commentary
Dowell D, Haegerich TM, Chou R. MMWR Recomm Rep. 2016;65:1-49.
Opioid pain medications carry high risk for adverse drug events and misuse. Due to climbing rates of opioid use and associated adverse events, the Centers for Disease Control and Prevention released new guidelines for prescribing opioid medications for chronic pain. These guidelines do not apply to patients receiving cancer treatment, palliative care, or end-of-life care. The authors recommend using opioids for chronic pain only if nonopioid medications and nonpharmacologic approaches to chronic pain are not effective and prescribing immediate-release instead of long-acting medications. For acute pain, they recommend limiting duration of therapy, stating that more than 1 week of medications should rarely be needed. The guidelines also suggest minimizing concurrent use of opioids and other sedating medications and dispensing naloxone to prevent overdoses. A previous WebM&M commentary describes an adverse event related to opioids.
Legislation/Regulation > Government Resource
Atlanta, GA: Centers for Disease Control and Prevention; May 2, 2012.
This statement describes the Centers for Disease Control and Prevention's guidelines on appropriate use of single-dose vials to prevent disease transmission.
Legislation/Regulation > Database/Directory
Bethesda, MD: American Society of Health-System Pharmacists.
This searchable listing of the American Society of Health-System Pharmacists policy and guideline collection provides user access to various content areas relevant to safe inpatient medication administration. The 2018 enhancements include a revision of the "ASHP Guidelines on Preventing Medication Errors in Hospitals".